These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

552 related items for PubMed ID: 9269988

  • 1. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.
    Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM.
    Cancer Res; 1997 Aug 15; 57(16):3325-30. PubMed ID: 9269988
    [Abstract] [Full Text] [Related]

  • 2. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
    Jeet V, Ow K, Doherty E, Curley B, Russell PJ, Khatri A.
    Prostate; 2008 Apr 01; 68(5):548-62. PubMed ID: 18247402
    [Abstract] [Full Text] [Related]

  • 3. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ, Mohan S, Cohen P, Foster BA, Greenberg NM.
    Cancer Res; 1999 May 01; 59(9):2203-9. PubMed ID: 10232609
    [Abstract] [Full Text] [Related]

  • 4. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.
    Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.
    Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM.
    Prostate; 2003 May 15; 55(3):219-37. PubMed ID: 12692788
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
    Wu GJ, Fu P, Chiang CF, Huss WJ, Greenberg NM, Wu MW.
    J Urol; 2005 May 15; 173(5):1778-83. PubMed ID: 15821586
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metastatic prostate cancer in a transgenic mouse.
    Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM.
    Cancer Res; 1996 Sep 15; 56(18):4096-102. PubMed ID: 8797572
    [Abstract] [Full Text] [Related]

  • 12. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.
    Gupta S, Ahmad N, Marengo SR, MacLennan GT, Greenberg NM, Mukhtar H.
    Cancer Res; 2000 Sep 15; 60(18):5125-33. PubMed ID: 11016639
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bcl-2 accelerates multistep prostate carcinogenesis in vivo.
    Bruckheimer EM, Brisbay S, Johnson DJ, Gingrich JR, Greenberg N, McDonnell TJ.
    Oncogene; 2000 Nov 02; 19(46):5251-8. PubMed ID: 11077442
    [Abstract] [Full Text] [Related]

  • 16. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
    Schmittgen TD, Zakrajsek BA, Hill RE, Liu Q, Reeves JJ, Axford PD, Singer MJ, Reed MW.
    Prostate; 2003 Jun 01; 55(4):308-16. PubMed ID: 12712410
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C, Altman NH, Mehta PP, Deftos LJ, Roos BA.
    Cancer Res; 1997 Mar 01; 57(5):900-6. PubMed ID: 9041192
    [Abstract] [Full Text] [Related]

  • 18. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.
    Prostate; 2008 May 15; 68(7):715-27. PubMed ID: 18302222
    [Abstract] [Full Text] [Related]

  • 19. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
    Wang J, Eltoum IE, Lamartiniere CA.
    Mol Cell Endocrinol; 2004 Apr 30; 219(1-2):171-80. PubMed ID: 15149738
    [Abstract] [Full Text] [Related]

  • 20. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW.
    Prostate; 2008 Oct 01; 68(14):1561-9. PubMed ID: 18663728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.